- 12/8/11 •
NanoString Technologies Announces Positive Results from First Validation Study of PAM50-based Breast Cancer Assay
- 11/07/11 •
NanoString Secures $20M in Series D Financing
- 10/12/2011 •
NanoString Announces Launch of Second Generation nCounter Analysis System
- 09/21/2011 •
NanoString Introduces Solution for Simultaneously Measuring miRNA and mRNA Expression Levels
- 08/05/2011 •
NanoString Introduces Rat miRNA Expression Assays
- 08/03/2011 •
NanoString Embarks on First in Series of Clinical Studies for Breast Cancer Intrinsic Subtyping Assay
| Febuary 2–3, 2012 | Dechema: Functional Genomics and Proteomics |
| Frankfurt am Main, Germany | |
| February 19–23, 2012 | Molecular Medicine Tri-Conference (MMTC) |
| San Francisco, CA | |
| March 11–15, 2012 | Society of Toxicology Annual Meeting |
| San Francisco, CA | |
| March 31– April 4, 2012 | American Association for Cancer Research Annual Meeting (AACR) |
| Chicago, IL |
- 10/21/2011 •
The NEW nSolver Analysis Software is now available and free of charge to nCounter users
- 10/12/11 •
The NEW GEN2 nCounter System is now available.
- 9/20/2011 •
miRGE CodeSets are now available
- 8/5/2011 •
The nCounter Rat microRNA Expression Assay is now available
- 7/28/11 •
NanoString launches new assay kit for characterization of leukemia fusion genes and biomarkers
- 7/22/11 •
Click to watch: Univ. of Geneva and NanoString: Tracking Genetic Clues
- 02/22/2011 •
The nCounter Human Karyotype Panel is now available.












